Baader Bank Aktiengesellschaft’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
2,357
+1,247
| +112% | +$554K | 0.08% | 136 |
|
|
2025
Q1 | $513K | Sell |
1,110
-1,366
| -55% | -$631K | 0.04% | 182 |
|
|
2024
Q4 | $997K | Buy |
2,476
+38
| +2% | +$15.3K | 0.07% | 129 |
|
|
2024
Q3 | $1.12M | Buy |
2,438
+45
| +2% | +$20.8K | 0.07% | 125 |
|
|
2024
Q2 | $1.12M | Buy |
2,393
+558
| +30% | +$261K | 0.07% | 134 |
|
|
2024
Q1 | $767K | Buy |
1,835
+325
| +22% | +$136K | 0.05% | 156 |
|
|
2023
Q4 | $614K | Sell |
1,510
-464
| -24% | -$189K | 0.04% | 171 |
|
|
2023
Q3 | $686K | Buy |
1,974
+6
| +0.3% | +$2.08K | 0.05% | 145 |
|
|
2023
Q2 | $691K | Sell |
1,968
-266
| -12% | -$93.4K | 0.03% | 138 |
|
|
2023
Q1 | $702K | Buy |
2,234
+24
| +1% | +$7.54K | 0.04% | 154 |
|
|
2022
Q4 | $638K | Hold |
2,210
| – | – | 0.03% | 169 |
|
|
2022
Q3 | $640K | Sell |
2,210
-420
| -16% | -$122K | 0.04% | 171 |
|
|
2022
Q2 | $741K | Buy |
+2,630
| New | +$741K | 0.06% | 147 |
|